Serum levels of soluble intercellular adhesion molecule-1 and soluble vascular cell adhesion molecule-1 in liver disease, and their changes by treatment with interferon

Journal of International Medical Research

Volumn 24, Issue 3, 1996, Pages 258-265

  Marui, A ^a   Fukuda, Y ^a   Koyama, Y ^a   Nakano, I ^a   Urano, F ^a   Yamada, M ^a   Hayakawa, T ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis; Hepatocellular carcinoma; Intercellular adhesion molecule 1; Interferon; Liver cirrhosis; Vascular cell adhesion molecule 1

Indexed keywords

ANTIVIRUS AGENT; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030005460     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/030006059602400304     Document Type: Article

References (27)

1. Volpes R, van Den Oord JJ, Desmet VJ: Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology 1990; 12: 59-65.
2. Volpes R, van Den Oord JJ, Desmet VJ: Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology 1992; 15: 269-275.
3. Hyodo I, Jinno K, Tanimizu M, et al: Detection of circulating intercellular adhesion molecule-1 in hepatocellular carcinoma. Int J Cancer 1993; 55: 775-779.
4. Torii A, Harada A, Nakao A, et al: Expression of intercellular adhesion molecule-1 in hepatocellular carcinoma. J Surg Oncol 1993; 53: 239-242.
5. Adams DH, Mainolfi E, Burra P, et al: Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 1992; 16: 810-814.
6. Horiike N, Onji M, Kumamato I, et al: Soluble intercellular adhesion molecule-1 in serum in chronic hepatitis B and C. J Gastroenterol 1994; 29: 455-459.
7. Lim AG, Jazrawi RP, Ahmed HA, et al: Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis. Hepatology 1994; 20: 882-888.
8. Adams DH, Burra P, Hubscher SG, et al. Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology 1994; 19: 588-594.
9. Lim AG, Jazrawi RP, Levy JH, et al: Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis. J Hepatol 1995; 22: 416-422.
10. Adams DH, Hubscher SG, Shaw J, et al: Increased expression of intercellular adhesion molecule-1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991; 14: 426-431.
11. Horiike N, Onji M, Kumon I, et al: Intercellular adhesion molecule-1 expression on the hepatocyte membrane of patients with chronic hepatitis B and C. Liver 1993; 13: 10-14.
12. Doi T, Yamada G, Mizuno M, et al: Immunohistochemical study of the distribution of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in chronic type B hepatitis. J Gastroenterol 1994; 29: 164-171.
13. Hu KQ, Yu CH, Vierling JM: Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein. Proc Natl Acad Sci USA 1992; 89: 11441-11445.
14. Rothlein R, Mainolfi EA, Czajkowski M, et al: A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-3793.
15. De Fougerolles AR, Stacker SA, Schwarting R, et al: Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991; 174: 253-267.
16. Nakamura S, Ohtani H, Watanabe Y, et al: In situ expression of the cell adhesion molecules in inflammatory bowel disease. Lab Invest 1993; 69: 77-85.
17. Maeda K, Kosco-Vilbois MH, Burton GF, et al: Expression of the intercellular adhesion molecule-1 on high endothelial venules and on non-lymphoid antigen handling cells: interdigitating cells, antigen transporting cells and follicular dendritic cells. Cell Tissue Res 1995; 279: 47-54.
18. van Den Oord JJ, Volpes R, Desmet VJ: Dendritic cells and the liver. APMIS 1991; 23: 68-76.
19. Kumon I: In situ characterization of mononuclear cell phenotype in intrahepatic lymphoid follicles in patients with chronic viral hepatitis. Gastroenterol Jpn 1992; 27: 638-645.
20. Mosnier JF, Degott C, Marcellin P, et al: The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology 1993; 17: 366-371.
21. Mosnier JF, Scoazec JY, Marcellin P, et al: Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C. Gastroenterology 1994; 107: 1457-1468.
22. Pirisi M, Falleti E, Fabris C, et al: Circulating intercellular adhesion molecule-1 (cICAM-1) concentration in liver disease; Relationship with cholestasis and functioning hepatic mass. Am J Clin Pathol 1994; 102: 600-604.
23. Nouri-Aria KT, Koskinas J, Tibbs CJ, et al: Serum intercellular adhesion molecule-1 levels in chronic hepatitis C: association with disease activity and response to interferon α. Gut 1995; 36: 599-603.
24. García-Monzón C, García-Buey L, García-Sánchez A, et al: Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic hepatitis treated with interferon alfa-2b. Gastroenterology 1993; 105: 462-469.
25. Eguchi K, Kawakami A, Nakashima M, et al: Interferon-alpha and dexamethasone inhibit adhesion of T cells to endothelial cells and synovial cells. Clin Exp Immunol 1992; 88: 448-454.
26. García-Monzón C, Sánchez-Madrid F, García-Buey L, et al: Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tract. Gastroenterology 1995; 108: 231-241.
27. Tsujisaki M, Imai K, Hirata H, et al: Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol 1991; 85: 3-8.